연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
951. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.
Lee SA, Ryu HW, Kim YM, Choi S, Lee MJ, Kwak TK, Kim HJ, Cho M, Park KH, Lee JW.
Hepatology. 2009 Apr;49(4):1316-25.
Link
950. Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44.
Kang JS, Bae SY, Kim HR, Kim YS, Kim DJ, Cho BJ, Yang HK, Hwang YI, Kim KJ, Park HS, Hwang DH, Cho DJ, Lee WJ.
Carcinogenesis. 2009 Dec;30(12):1987-96.
Link
949. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
Kim M, Yim SH, Cho NS, Kang SH, Ko DH, Oh B, Kim TY, Min HJ, She CJ, Kang HJ, Shin HY, Ahn HS, Yoon SS, Kim BK, Shin HR, Han KS, Cho HI, Lee DS.
Cancer Genet Cytogenet. 2009 Nov;195(1):59-65.
Link
948. Multiple Myeloma Working Party (KMMWP).Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interaction.
Kim TY, Park J, Oh B, Min HJ, Jeong TS, Lee JH, Suh C, Cheong JW, Kim HJ, Yoon SS, Park SB, Lee DS; Korean Br J Haematol. 2009 Aug;146(3):270-81. Epub 2009 Jun 3.
947. Non-A type nucleophosmin 1 gene mutation predicts poor clinical outcome in de novo adult acute myeloid leukemia: differential clinical importance of NPM1 mutation according to subtype.
Koh Y, Park J, Bae EK, Ahn KS, Kim I, Bang SM, Lee JH, Yoon SS, Lee DS, Lee YY, Park S, Kim BK.
Int J Hematol. 2009 Jul;90(1):1-5. Epub 2009 May 30.
Link
946. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y, Park J, Ahn KS, Kim I, Bang SM, Lee JH, Yoon SS, Soon Lee D, Yiul Lee Y, Park S, Kim BK.
Ann Hematol. 2009 Nov;88(11):1089-97. Epub 2009 Mar 19.
Link
945. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
Wu HG, Song SY, Kim YS, Oh YT, Lee CG, Keum KC, Ahn YC, Lee SW.
Cancer. 2009 Aug 15;115(16):3699-708.
Link
944. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
Kim K, Wu HG, Kim HJ, Sung MW, Kim KH, Lee SH, Heo DS, Kim HJ, Park CI.
Head Neck. 2009 Sep;31(9):1121-8.
Link
943. The Safety of the Dissection of LymphNode Stations 5 and 6 in Pylorus-Preserving Gastrectomy.
Kong SH, Kim JW, Lee HJ, Kim WH, Lee KU, Yang HK.
Ann Surg Oncol. 2009 Jul 29. [Epub ahead of print]
Link
942. Evaluation of the Adequacy of Lymph Node Dissection in Pylorus-Preserving Gastrectomy for Early Gastric Cancer Using the Maruyama Index.
Yoo MW, Park DJ, Ahn HS, Jeong SH, Lee HJ, Kim WH, Kim HH, Lee KU, Yang HK.
World J Surg.. [Epub ahead of print]
Link